Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

In the fiscal first quarter, Cardiovascular revenues increased 6.9% ... We expect an in-line return from the stock in the next few months. Medtronic is part of the Zacks Medical - Products industry.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Product innovation driving growth is a major theme for Medtronic. Over the past year ... that works with the MiniMed 780G. The larger Cardiovascular business has also been a strong point, with ...

The company operates in four business segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. Medtronic sells products in many end markets in these segments. It is usually the ...

In 2023, covered stents and femoral artery stents led the market in terms of technology and product type ... market share due ...